Lupus Patients And The Vaccine Booster
By Dr. Robert Katz Medical Advisory Board Pharmacies are now offering booster shots for immunocompromised patients. Many lupus patients qualify because they are being treated with prednisone and [...]
COVID-19 Update – Delta Variant & Vaccine Information
By Dr. Robert Katz According to the CDC, the Delta variant of COVID-19 is more contagious – more than 2x as contagious as previous variants; some data suggest the Delta variant might cause [...]
SAPHNELO FAQ
What is SAPHNELO and how does it work?SAPHNELO is a first-in-class type I interferon (IFN) receptor antagonist, a human monoclonal antibody that binds to subunit 1 of the type I IFN receptor, [...]
Europe has now approved the use of Benlysta to treat children with lupus
By Dr. Robert Katz Europe has now approved the use of Benlysta to treat children with lupus. Benlysta has the generic name belimumab. The “mab” at the end indicates it is a monoclonal antibody. [...]
Lupus & Cancer Risk Article Review
By Dr. Robert Katz In a paper written by Rasmus, Westermann, and others, the authors ask the question as to whether cancer risk is increased in patients with skin lupus and systemic lupus [...]
Lupus & Pregnancy Article Review
By Dr. Robert Katz A research paper in the journal Lupus entitled, “The Importance of Pregnancy Planning in Lupus Pregnancies,” Rajendran, Euty, and other authors from Duke University Medical [...]
Delayed Diagnosis Adversely Affects Outcome in Systemic Lupus Erythematosus: Article Review
By Dr. Robert Katz An article in the journal Lupus discusses delayed diagnosis. The conclusion of the authors is that a longer time to diagnosis was associated with worse outcomes. The average [...]
ROBERT KATZ, M.D. ELECTED CHAIR, LUPUS SOCIETY OF ILLINOIS BOARD OF DIRECTORS
Dr. Katz takes leadership role after decades-long commitment to the lupus community (CHICAGO, IL−May 11, 2021)- Dr. Robert S. Katz has been elected Chairman of the Board of the Lupus Society of [...]
